8 Knots Management LLC acquired a new position in UnitedHealth Group Incorporated (NYSE: UNH) in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 275,022 shares of the healthcare conglomerate's stock, valued at approximately $94,965,000. UnitedHealth Group accounts for about 10.7% of 8 Knots
Glenmede Investment Management LP lifted its position in shares of UnitedHealth Group Incorporated (NYSE: UNH) by 6.1% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 132,999 shares of the healthcare conglomerate's stock after buying an additional 7,627 shares during the quarter.
Game Creek Capital LP boosted its holdings in shares of UnitedHealth Group Incorporated (NYSE: UNH) by 106.4% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 15,375 shares of the healthcare conglomerate's stock after buying an additional 7,925 shares
UnitedHealth (UNH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Arrowstreet Capital Limited Partnership increased its stake in UnitedHealth Group Incorporated (NYSE: UNH) by 17.3% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,401,853 shares of the healthcare conglomerate's stock after buying an additional 502,474 shares during the
UnitedHealth Group Incorporated (UNH) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
UnitedHealth Group (UNH) closed the most recent trading day at $285.25, moving +1.03% from the previous trading session.
Markwayne Mullin, American politician serving as Oklahoma's junior United States senator, has filed a new Periodic Transaction Report, revealing a rather suspicious joint stock purchase.
UnitedHealth rolls out AI in Optum Rx to flag pharmacy fraud, billing anomalies and medication risks, aiming to curb cost leakage and improve compliance.
UNH faces rising medical costs, regulatory probes and a healthcare hiring slump while shares keep falling, leaving investors weighing risk or opportunity.
The latest trading day saw UnitedHealth Group (UNH) settling at $289.21, representing a -1.94% change from its previous close.
UnitedHealth is upgraded to 'Buy' as pessimism appears overdone and shares trade near a strong $300 support with compelling valuation metrics. UNH's scale, AI-driven cost efficiencies, and exposure to an aging U.S. population position it for long-term EPS and revenue recovery despite near-term stagnation. The stock offers a 3% forward dividend yield with a low 53% payout ratio and a solid record of dividend growth, appealing to income investors.